Ultimately, despite its successes elsewhere, the NIH has struggled with effective outreach. Representatives from a National Academies’ panel advocate for a more comprehensive strategy that supports minority scientists earlier on in their career in lieu of quotas, which are considered by some as dilutive of application quality.